These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1874917)

  • 1. Assay of anti-HBs antibodies using a recombinant antigen and latex particle counting: comparison with five commercial tests.
    Galanti LM; Cornu C; Masson PL; Robert AR; Becheanu D; Lamy ME; Cambiaso CL
    J Virol Methods; 1991 May; 32(2-3):221-31. PubMed ID: 1874917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to HBsAg differently interpreted by RIA and EIA.
    Kruining J; Mulder PG; Heijtink RA
    J Virol Methods; 1988 Oct; 22(1):89-98. PubMed ID: 3058738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of micro particle enzyme immunoassay (MEIA) for the demonstration of antibody to hepatitis B surface antigen].
    Kashiwagi S; Hayashi J; Noguchi A; Nakashima K; Hirata M; Kajiyama W
    Kansenshogaku Zasshi; 1992 Mar; 66(3):390-9. PubMed ID: 1624829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of Hepatitis B Surface antibody levels in subjects receiving universal Hepatitis B vaccination in infancy in an area of hyperendemicity: correlation between radioimmunoassay and enzyme immunoassay.
    Wang CW; Wang LC; Chang MH; Ni YH; Chen HL; Hsu HY; Chen DS
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1442-7. PubMed ID: 16339069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of enzyme- and radio-immunoassay kits to detect hepatitis B surface antibody response among hepatitis B vaccinees.
    Lee SD; Lo KJ; Tsai YT; Chan CY; Lin HC; Wu JC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Aug; 21(3):158-64. PubMed ID: 3072155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and technical and clinical validation of a quantitative enzyme-linked immunosorbent assay for the detection of human antibodies to hepatitis B surface antigen in recipients of recombinant hepatitis B virus vaccine.
    Cambron P; Jacquet JM; Hoet B; Lievens M
    Clin Vaccine Immunol; 2009 Aug; 16(8):1236-46. PubMed ID: 19553553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two techniques for detecting antibody to HBsAg during a hepatitis B vaccine study.
    Heijtink RA; Kruining J; Schalm SW; Masurel N
    J Virol Methods; 1985 Apr; 10(4):333-9. PubMed ID: 2581987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second generation assays for the detection of antibody to HBsAg using recombinant DNA-derived HBsAg.
    Mimms L; Goetze A; Swanson S; Floreani M; Edwards B; Macioszek J; Okasinski G; Kiang W
    J Virol Methods; 1989 Aug; 25(2):211-31. PubMed ID: 2476461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of isolated hepatitis B core antibodies detected by enzyme immunoassay in a high risk population.
    Kroes AC; Quint WG; Heijtink RA
    J Med Virol; 1991 Oct; 35(2):96-100. PubMed ID: 1765777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoassay of hepatitis B surface antigen by particle counting after pepsin digestion.
    Galanti LM; Cambiaso CL; Cornu CJ; Lamy ME; Masson PL
    J Virol Methods; 1987 Dec; 18(4):215-23. PubMed ID: 3127414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of enzyme immunoassay (EIA) as a screening method for hepatitis B markers in an open population.
    McCready JA; Morens D; Fields HA; Coleman PJ; Kane M; Schatz G
    Epidemiol Infect; 1991 Dec; 107(3):673-84. PubMed ID: 1752314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of enzyme immunoassay with radioimmunoassay for the detection of antibody to hepatitis B core antigen as the only marker of hepatitis B infection in a population with a high prevalence of hepatitis B.
    Parkinson AJ; McMahon BJ; Hall D; Ritter D; Fitzgerald MA
    J Med Virol; 1990 Apr; 30(4):253-7. PubMed ID: 2196336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
    Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw2, adr, ayw3) in measuring the immune response after vaccination.
    Heijtink RA; Bergen Pv; Melber K; Janowicz ZA; Osterhaus AD
    Vaccine; 2002 May; 20(17-18):2191-6. PubMed ID: 12009272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurements in international units of antibody to hepatitis B surface antigen(anti-HBs) after immunization with a yeast-derived, subtype adr hepatitis B vaccine are considerably different between chemiluminescent immunoassay (CLIA) and chemiluminescent enzyme immunoassay (CLEIA).
    Ogata N
    Rinsho Byori; 2006 Apr; 54(4):340-3. PubMed ID: 16722452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single Center Analysis of the Positivity of Hepatitis B Antibody after Neonatal Vaccination Program in Korea.
    Kim YJ; Li P; Hong JM; Ryu KH; Nam E; Chang MS
    J Korean Med Sci; 2017 May; 32(5):810-816. PubMed ID: 28378555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccination of haemodialysis patients: randomized controlled trial comparing plasma-derived vaccine with and without pre-S2 antigen.
    Smit-Leijs MB; Kramer P; Heijtink RA; Hop WC; Schalm SW
    Eur J Clin Invest; 1990 Oct; 20(5):540-5. PubMed ID: 2124986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines.
    Heijtink RA; van Bergen P; Paulij WP; de Man RA; Osterhaus AD
    Vaccine; 2000 Feb; 18(15):1531-8. PubMed ID: 10618551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibody persistence following primary vaccination with hepatitis B vaccine among normal and high-responder adults: a 5-year follow-up study].
    Wu WL; Yan BY; Lyu JJ; Liu JY; Feng Y; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang GM; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):484-90. PubMed ID: 27256726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of enhanced chemiluminescence and microparticle enzyme immunoassay for the measurement of hepatitis B surface antibody.
    McCartney RA; Harbour J; Roome AP; Caul EO
    Vaccine; 1993; 11(9):941-5. PubMed ID: 8212842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.